Marex Group plc Ordinary Shares (MRX) — Defensive Interval Ratio
Marex Group plc Ordinary Shares (MRX) has a Defensive Interval Ratio of 854 days as of December 2025. Defensive assets of $18.15 Billion (cash $-, short-term investments $7.08 Billion, receivables $11.07 Billion) cover 854 days of daily cash needs of $21.24 Million/day. See Marex Group plc Ordinary Shares (MRX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Marex Group plc Ordinary Shares Defensive Interval Ratio (2021–2025)
This chart shows how Marex Group plc Ordinary Shares's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 854 days, meaning defensive assets of $18.15 Billion can fund 854 days of operations without new revenue. See MRX net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Marex Group plc Ordinary Shares (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Marex Group plc Ordinary Shares from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Marex Group plc Ordinary Shares (MRX) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 854 days | $18.15 Billion | $21.24 Million/day | $- | $7.08 Billion | ▲ +650 days |
| 2024 | 205 days | $12.21 Billion | $59.67 Million/day | $- | $2.66 Billion | ▼ -47 days |
| 2023 | 252 days | $10.96 Billion | $43.52 Million/day | $- | $3.25 Billion | ▼ -33 days |
| 2022 | 284 days | $11.35 Billion | $39.90 Million/day | $- | $2.31 Billion | ▲ +109 days |
| 2021 | 175 days | $2.22 Billion | $12.69 Million/day | $- | $46.30 Million | — |